Home / Companies / Syndax Pharmaceuticals, Inc. / 10 Jun 2026
Syndax Pharmaceuticals, Inc.: meeting of 10 Jun 2026
Votes reported on Form N-PX, item by item
348 Form N-PX filers reported votes at the Syndax Pharmaceuticals, Inc. meeting of 10 Jun 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 77.5% of reported votes for; 53 filers withheld from or voted against at least one nominee.
405 vote records from 110 filers. 1 of the 110 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
505 vote records from 346 filers. 28 of the 333 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
203 vote records from 110 filers. 1 of the 110 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
18 vote records from 11 filers. 0 of the 11 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
396 vote records from 111 filers. 3 of the 111 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | For | No report |
| State Street and SPDR | For | For | For |
| American Century | No report | Against * | No report |
| Franklin Templeton | Split or no vote | For | For |
| Invesco | For | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | Split or no vote | For | For |
| John Hancock and Manulife | Split or no vote | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Split or no vote | For | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | For | For | For |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | Split or no vote | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | For | For |
| Voya | Split or no vote | For | For |
| First Trust | Split or no vote | For | For |
| Russell Investments | No report | For | No report |
| Nationwide | For | For | For |
| Victory Capital | Split or no vote | For | For |
| Brighthouse Funds | For | For | For |
| Guggenheim and Rydex | Split or no vote | For | For |
| Columbia Threadneedle | For | For | For |
| BNY Mellon | For | For | For |
| Principal | Split or no vote | For | For |
| Pacific Life funds | For | For | For |
| Global X | Split or no vote | For | For |
| AllianceBernstein | No report | For | No report |
| DWS | Split or no vote | For | For |
| Allspring | Split or no vote | For | For |
| MassMutual | No report | For | No report |
| Harbor Funds | Split or no vote | For | For |
| Macquarie and Delaware Funds | Split or no vote | For | For |
| Neuberger Berman | No report | For | No report |
| Natixis and Loomis Sayles | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Syndax Pharmaceuticals, Inc. meeting?
348 Form N-PX filers reported votes at the meeting of 10 Jun 2026. On say-on-pay, 28 of 333 voted against management (8.4%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Syndax Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Syndax Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Syndax Pharmaceuticals, Inc. with a meeting date within three days of 10 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.